Picture of Baikang Biological group logo

BKSW Baikang Biological group Income Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesMicro Cap

Annual income statement for Baikang Biological group, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

2017
April 30th
2018
April 30th
Period Length:12 M12 M
Source:PROSPECTUSPROSPECTUS
Standards:
USG
USG
Status:FinalFinal
Revenue
Total Revenue14.726.8
Cost of Revenue
Gross Profit11.620.4
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses5.919.44
Operating Profit8.7717.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes8.6817.6
Provision for Income Taxes
Net Income After Taxes7.3814.9
Minority Interest
Net Income Before Extraordinary Items
Net Income7.3714.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income7.3714.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.3070.621
Dividends per Share